Topline<\/p>\n
Donald Trump went after Tylenol again in a Truth Social post Friday, urging pregnant women to avoid the drug, causing parent company Kenvue\u2019s shares to slip.<\/p>\n
WASHINGTON, DC – JUNE 15: U.S. President Donald Trump stops and talks to the media before he boards Marine One on the South Lawn at the White House on June 15, 2025 in Washington, DC. The President will attend the annual meeting of the Group of 7 nations, Britain, Canada, France, Germany, Italy, Japan and the United States are taking place in the Canadian Rocky Mountains in Alberta, and will run until late Tuesday. (Photo by Tasos Katopodis\/Getty Images)<\/p>\n
Getty ImagesKey Facts<\/p>\n
President Trump warned women to avoid Tylenol \u201cunless absolutely necessary\u201d in a post on Truth Social<\/a> Friday.<\/p>\n The president also said that the measles, mumps and rubella vaccines should be taken in three separate shots, and the hepatitis B vaccine should only be taken when the children are 12 years or older, contradicting CDC claims<\/a> there was no scientific evidence showing it was beneficial to separate the vaccines.<\/p>\n The president made similar statements during a press conference at the White House on September 22nd, after which the Food and Drug Administration (FDA) announced<\/a> it was changing the labels on Tylenol bottles to suggest that it may cause autism and ADHD in children whose mothers took the drug when they were pregnant.<\/p>\n Most studies, including a 2024 study<\/a> by the Journal of the American Medical Association have found no link between acetaminophen, the active ingredient in Tylenol, and autism.<\/p>\n Shares of Kenvue, the company that produces Tylenol, fell close to 2% to $16.17 after the post, but have since recovered. <\/p>\n Kenvue\u2019s shares are down more than 20% this month amid multiple comments from the Trump administration linking usage of Tylenol by pregnant women with an increased risk of autism in infants.<\/p>\n Key Background<\/strong><\/p>\n Tylenol is owned by Kenvue\u2019s subsidiary McNeil Consumer Healthcare. More than 52 million people in the United States use the over-the-counter medicine every week, according<\/a> to the nonprofit Consumer Healthcare Products Association. While some studies have shown a connection between acetaminophen and autism, they have not proven a causal link, despite claims from Health Secretary Robert F. Kennedy that acetaminophen is a possible cause. <\/p>\n Kennedy\u2019s focus on Tylenol began after a meeting <\/a>with Kenvue\u2019s CEO earlier this month, after which he and his team sounded a warning to physicians on the issue. Trump\u2019s warnings have resurfaced a barrage of litigation over the issue \u2013 a federal court dismissed<\/a> lawsuits alleging a link between Tylenol and developmental disorder in December. <\/p>\n Further Reading<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"Topline Donald Trump went after Tylenol again in a Truth Social post Friday, urging pregnant women to avoid…\n","protected":false},"author":3,"featured_media":257073,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[824,210,132611,1060,28186,277,5200,47486,67,132,68],"class_list":{"0":"post-257072","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-autism","9":"tag-health","10":"tag-kenvue","11":"tag-medication","12":"tag-robert-f-kennedy","13":"tag-trump","14":"tag-truth-social","15":"tag-tylenol","16":"tag-united-states","17":"tag-unitedstates","18":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115272784609150788","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/257072","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=257072"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/257072\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/257073"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=257072"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=257072"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=257072"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}